Mrassf1a-Pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Van Den Oever, Jessica M E ^a   Balkassmi, Sahila ^a   Segboer, Tim ^a   Verweij, E Joanne ^a   Van Der Velden, Pieter A ^a   Oepkes, Dick ^a   Bakker, Egbert ^a   Boon, Elles M J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BASE SEQUENCE; CELL-FREE SYSTEM; DNA; DNA METHYLATION; FEMALE; FETUS; GENETIC MARKERS; GENOTYPE; GESTATIONAL AGE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR SUPPRESSOR PROTEINS;

EID: 84894181406     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084051     Document Type: Article

References (38)

1. Tang NL, Leung TN, Zhang J, Lau TK, Lo YM (1999) Detection of fetal-derived paternally inherited X-chromosome polymorphisms in maternal plasma. Clin Chem 45: 2033-2035. (Pubitemid 29522022)
2. Alizadeh M, Bernard M, Danic B, Dauriac C, Birebent B, et al. (2002) Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 99: 4618-4625. (Pubitemid 34627235)
3. Page-Christiaens GC, Bossers B, van der Schoot CE, de Haas M (2006) Use of bi-allelic insertion/deletion polymorphisms as a positive control for fetal genotyping in maternal blood: first clinical experience. Ann N Y Acad Sci 1075: 123-129. 1075/1/123 [pii];10.1196/annals.1368.016 [doi].
4. Hill M, Finning K, Martin P, Hogg J, Meaney C, et al. (2010) Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet. 10.1111/j.1399-0004.2010.01533.x [doi].
5. Scheffer PG, van der Schoot CE, Page-Christiaens GC, Bossers B, van Erp F, et al. (2010) Reliability of fetal sex determination using maternal plasma. Obstet Gynecol 115: 117-126. 10.1097/AOG.0b013e3181c3c938 [doi];00006250- 201001000-00019 [pii].
6. Bachmann N, Bergmann C (2012) Epigenetics and imprinting. Arch Pediatr 19: 1145-1147. S0929-693X(12)00358-2 [pii];10.1016/j.arcped.2012.08.004 [doi].
7. Poon LL, Leung TN, Lau TK, Chow KC, Lo YM (2002) Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem 48: 35-41. (Pubitemid 34038120)
8. Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ (2006) Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol 169: 400-404. S0002-9440(10)62723-X [pii];10.2353/ajpath.2006.060161 [doi].
9. Alberry M, Maddocks D, Jones M, Abdel HM, Abdel-Fattah S, et al. (2007) Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 27: 415-418. 10.1002/pd.1700 [doi]. (Pubitemid 47164339)
10. Bianchi DW (2004) Circulating fetal DNA: its origin and diagnostic potential-a review. Placenta 25 Suppl A: S93-S101. 10.1016/j.placenta.2004.01. 005 [doi];S0143400404000190 [pii].
11. Faas BH, de Ligt J, Janssen I, Eggink AJ, Wijnberger LD, et al. (2012) Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells. Expert Opin Biol Ther 12 Suppl 1: S19-S26. 10.1517/14712598.2012.670632 [doi].
12. Chim SS, Tong YK, Chiu RW, Lau TK, Leung TN, et al. (2005) Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A 102: 14753-14758. 0503335102 [pii];10.1073/pnas.0503335102 [doi].
13. Chiu RW, Chim SS, Wong IH, Wong CS, Lee WS, et al. (2007) Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol 170: 941-950. S0002-9440(10)60915-7 [pii];10.2353/ajpath.2007.060641 [doi].
14. Chim SS, Jin S, Lee TY, Lun FM, Lee WS, et al. (2008) Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem 54: 500-511. clinchem.2007.098731 [pii];10.1373/clinchem.2007.098731 [doi].
15. Tong YK, Ding C, Chiu RW, Gerovassili A, Chim SS, et al. (2006) Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations. Clin Chem 52: 2194-2202. clinchem.2006.076851 [pii];10.1373/clinchem.2006.076851 [doi].
16. Tong YK, Chiu RW, Leung TY, Ding C, Lau TK, et al. (2007) Detection of restriction enzyme-digested target DNA by PCR amplification using a stem-loop primer: application to the detection of hypomethylated fetal DNA in maternal plasma. Clin Chem 53: 1906-1914. clinchem.2007.092619 [pii];10.1373/clinchem. 2007.092619 [doi].
17. Papageorgiou EA, Fiegler H, Rakyan V, Beck S, Hulten M, et al. (2009) Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol 174: 1609-1618. S0002-9440(10)61019-X [pii];10.2353/ajpath.2009.081038 [doi].
18. Bellido ML, Radpour R, Lapaire O, De Bie I, Hosli I, et al. (2010) MALDITOF mass array analysis of RASSF1A and SERPINB5 methylation patterns in human placenta and plasma. Biol Reprod 82: 745-750. biolreprod.109.082271 [pii];10.1095/biolreprod.109.082271 [doi].
19. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, et al. (2006) Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52: 2211-2218. clinchem.2006.074997 [pii];10.1373/clinchem.2006.074997 [doi].
20. Lun FM, Chiu RW, Leung TY, Leung TN, Lau TK, et al. (2007) Epigenetic analysis of RASSF1A gene in cell-free DNA in amniotic fluid. Clin Chem 53: 796-798. 53/4/796 [pii];10.1373/clinchem.2006.084350 [doi].
21. Della Ragione F, Mastrovito P, Campanile C, Conti A, Papageorgiou EA, et al. (2010) Differential DNA methylation as a tool for noninvasive prenatal diagnosis (NIPD) of X chromosome aneuploidies. J Mol Diagn 12: 797-807. S1525-1578(10)60130-4 [pii];10.2353/jmoldx.2010.090199 [doi].
22. Zhao F, Wang J, Liu R, Yang J, Cui K, et al. (2010) Quantification and application of the placental epigenetic signature of the RASSF1A gene in maternal plasma. Prenat Diagn 30: 778-782. 10.1002/pd.2546 [doi].
23. Tsui DW, Chan KC, Chim SS, Chan LW, Leung TY, et al. (2007) Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia. Prenat Diagn 27: 1212-1218. 10.1002/pd.1897 [doi]. (Pubitemid 350305436)
24. White HE, Dent CL, Hall VJ, Crolla JA, Chitty LS (2012) Evaluation of a novel assay for detection of the fetal marker RASSF1A: facilitating improved diagnostic reliability of noninvasive prenatal diagnosis. PLoS One 7: e45073. 10.1371/journal.pone.0045073 [doi];PONE-D-12-13129 [pii].
25. Boon EM, Schlecht HB, Martin P, Daniels G, Vossen RH, et al. (2007) Y chromosome detection by Real Time PCR and pyrophosphorolysis-activated polymerisation using free fetal DNA isolated from maternal plasma. Prenat Diagn 27: 932-937. 10.1002/pd.1804 [doi]. (Pubitemid 47597921)
26. Phylipsen M, Yamsri S, Treffers EE, Jansen DT, Kanhai WA, et al. (2012) Noninvasive prenatal diagnosis of beta-thalassemia and sickle-cell disease using pyrophosphorolysis-activated polymerization and melting curve analysis. Prenat Diagn 32: 578-587. 10.1002/pd.3864 [doi].
27. Liu Q, Sommer SS (2000) Pyrophosphorolysis-activated polymerization (PAP): application to allele-specific amplification. Biotechniques 29: 1072-6, 1078, 1080.
28. Shi J, Liu Q, Sommer SS (2007) Detection of ultrarare somatic mutation in the human TP53 gene by bidirectional pyrophosphorolysis-activated polymerization allele-specific amplification. Hum Mutat 28: 131-136. 10.1002/humu.20423 [doi]. (Pubitemid 46233309)
29. Liu Q, Sommer SS (2004) PAP: detection of ultra rare mutations depends on P* oligonucleotides: "sleeping beauties" awakened by the kiss of pyrophosphorolysis. Hum Mutat 23: 426-436. 10.1002/humu.20036 [doi].
30. van den Oever JM, Balkassmi S, Verweij EJ, van Iterson M, Adama van Scheltema PN, et al. (2012) Single molecule sequencing of free DNA from maternal plasma for noninvasive trisomy 21 detection. Clin Chem 58: 699-706. clinchem.2011.174698 [pii];10.1373/clinchem.2011.174698 [doi].
31. Li LC, Dahiya R (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics 18: 1427-1431.
32. Maat W, van der Velden PA, Out-Luiting C, Plug M, Dirks-Mulder A, et al. (2007) Epigenetic inactivation of RASSF1a in uveal melanoma. Invest Ophthalmol Vis Sci 48: 486-490. 48/2/486 [pii];10.1167/iovs.06-0781 [doi].
33. Milbury CA, Li J, Makrigiorgos GM (2009) PCR-based methods for the enrichment of minority alleles and mutations. Clin Chem 55: 632-640. clinchem.2008.113035 [pii];10.1373/clinchem.2008.113035 [doi].
34. Zhang Q, Hu G, Yang Q, Dong R, Xie X, et al. (2013) A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA. Gynecol Oncol 130: 132-139. S0090-8258(13)00304-1 [pii];10.1016/j.ygyno.2013.04.048 [doi].
35. Majchrzak-Celinska A, Paluszczak J, Kleszcz R, Magiera M, Barciszewska AM, et al. (2013) Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients. J Appl Genet 54: 335-344. 10.1007/s13353-013-0149-x [doi].
36. Ponomaryova AA, Rykova EY, Cherdyntseva NV, Skvortsova TE, Dobrodeev AY, et al. (2013) Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients. Lung Cancer 81: 397-403. S0169-5002(13)00248-1 [pii];10.1016/j.lungcan.2013.05.016 [doi].
37. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, et al. (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62: 768-775. S0002-9297(07)60967-7 [pii];10.1086/301800 [doi].
38. Lun FM, Chiu RW, Allen Chan KC, Yeung LT, Kin LT, et al. (2008) Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 54: 1664-1672. clinchem.2008.111385 [pii];10.1373/clinchem.2008.111385 [doi].